- Home
- GOODO vs MRK Comparison
GOODO vs MRK Comparison
Compare GOODO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GOODO
Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Current Price
Current Price
Company Overview
Basic Information| Metric | GOODO | MRK |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 317.8B |
| IPO Year | 2003 | 1997 |
Fundamental Metrics
Financial Performance| Metric | GOODO | MRK |
|---|---|---|
| Price | $17.86 | $146.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 27 |
| Target Price | N/A | ★ $158.64 |
| AVG Volume (30 Days) | 8.6K | ★ 6.0M |
| Earning Date | N/A | 10-29-2026 |
| Dividend Yield | N/A | ★ 2.34% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | ★ 0.18 | N/A |
| Revenue | $161,336,000.00 | ★ $65,011,000,000.00 |
| Revenue This Year | N/A | $3.13 |
| Revenue Next Year | N/A | $4.33 |
| P/E Ratio | $99.50 | ★ N/A |
| Revenue Growth | ★ 8.00 | 1.31 |
| 52 Week Low | $17.51 | $82.01 |
| 52 Week High | $22.20 | $157.00 |
Technical Indicators
Market Signals| Indicator | GOODO | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 30.04 | 52.44 |
| Support Level | $17.51 | $145.75 |
| Resistance Level | $20.32 | $153.19 |
| Average True Range (ATR) | 0.34 | 3.73 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 25.93 | 55.24 |
Price Performance
Historical ComparisonAbout GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).